Insulin Physiology in Pregnancy
Pregnancy induces progressive insulin resistance beginning in the second trimester, compensated by increased pancreatic β-cell insulin secretion and enhanced insulin clearance, creating a diabetogenic state that peaks in the third trimester. 1
Progressive Insulin Resistance
Pregnancy creates a state of physiological insulin resistance that develops exponentially during the second trimester and plateaus toward the end of the third trimester 1. This resistance is multifactorial and operates at the postreceptor level in skeletal muscle, the primary site of glucose disposal 2.
Molecular Mechanisms of Insulin Resistance
The insulin resistance operates through several specific pathways:
- Insulin receptor dysfunction: Alterations occur at the β-subunit of the insulin receptor and at insulin receptor substrate-1 (IRS-1) 2
- Phosphatidylinositol 3-kinase disruption: Increased free intracytoplasmic p85 subunit impairs insulin signaling 2
- Serine phosphorylation: Enhanced serine phosphorylation of the insulin receptor and IRS-1 competitively inhibits tyrosine phosphorylation, further blocking downstream insulin signaling 2
Hormonal Drivers
The insulin resistance is driven by pregnancy-induced factors, with placental growth hormone and tumor necrosis factor-α (TNF-α) being the most likely candidates 2. Additional placental hormones including human placental lactogen, interleukin-6, and leptin contribute to the exaggerated insulin resistance 2.
Compensatory β-Cell Response
Increased Insulin Secretion
Normal pregnancy triggers a dramatic compensatory increase in insulin secretion:
- Basal insulin levels increase by 65% with advancing gestation 3
- First-phase insulin secretion increases 3.0- to 3.5-fold during pregnancy 4
- Second-phase insulin secretion increases similarly (3.0- to 3.5-fold) 4
- The insulin/glucose ratio increases significantly throughout gestation 4
This represents an almost 4-fold increase in insulin response when the same glycemic stimulus is applied in pregnancy versus postpartum 5. The enhanced insulin responsiveness results from pregnancy-related changes in progesterone, estradiol, human placental lactogen, and prolactin secretion 5.
β-Cell Adaptation
Animal studies demonstrate β-cell hypertrophy and hyperplasia with increased insulin secretory responsiveness during pregnancy 5. This adaptation is essential because despite the massive increase in insulin secretion, it remains insufficient to fully overcome the insulin resistance, making pregnancy inherently a diabetogenic state.
Insulin Clearance Changes
The metabolic clearance rate of insulin increases significantly during pregnancy 3:
- Pregravid: 442 ml·m⁻²·min⁻¹
- Early pregnancy (12-14 weeks): 514 ml·m⁻²·min⁻¹
- Late pregnancy (34-36 weeks): 526 ml·m⁻²·min⁻¹
This represents a homeostatic response to the increased physiological insulin resistance, contributing to the hyperinsulinemia of pregnancy 3.
Suppression of Basal Insulin Secretion
An important finding is that the ability of exogenous insulin to suppress endogenous insulin secretion decreases progressively during pregnancy 3:
- C-peptide suppression: 64% before conception → 74% early pregnancy → 108% late pregnancy
- This means that by late pregnancy, basal β-cell secretion is no longer suppressible by exogenous insulin 3
Temporal Pattern
First Trimester
- Slight decrease or unchanged insulin sensitivity 6
- Maternal fasting plasma glucose slightly decreases 6
- Anabolic phase with increased maternal fat storage 6
- Insulin requirements often decrease in women with type 1 diabetes 1
Second Trimester
- Exponential increase in insulin resistance begins 1
- Compensatory increase in insulin secretion accelerates
- Rapidly increasing insulin requirements necessitate weekly or biweekly insulin dose adjustments 1
Third Trimester
- Insulin resistance peaks and plateaus 1
- Catabolic state with increased lipolysis 6
- Maximum insulin requirements
- Insulin requirements level off toward the end of the third trimester 7
Postpartum Resolution
Insulin resistance abates soon after delivery, with signaling changes returning to normal within 1 year postpartum in women with normal glucose tolerance 2. This confirms that the insulin resistance is driven by pregnancy-induced factors rather than permanent metabolic changes.
Insulin demand decreases dramatically with delivery of the placenta 8, followed by gradual increase in insulin resistance in the weeks following delivery, particularly in lactating women who face increased risk of nocturnal hypoglycemia 8.
Clinical Implications
The magnitude of insulin resistance in late pregnancy is substantial: whole-body insulin sensitivity decreases by approximately 50-67% compared to the non-pregnant state 9, 10, 4. This creates a critical window where women with inadequate β-cell reserve develop gestational diabetes when their pancreatic response cannot match the insulin resistance 2.